Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD. Wingerchuk DM, Fujihara K, Palace J, Berthele A, et al. Ann Neurol 2021;89:1088-1098.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wingerchuk DM, Fujihara K, Palace J, Berthele A, et al. Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD. Ann Neurol 2021;89:1088-1098.
PMID: 33586143